Skip to main content

URMC Logo

URMC / Research / Research@URMC
New Technologies May Speed Flu Vaccine Testing

New Technologies May Speed Flu Vaccine Testing

The AIR™ Platform, a silicon chip and imaging system marketed by Adarza Biosystems, can detect immune responses to flu virus and vaccines alike.  With a small blood sample, doctors can confirm a suspected flu infection, see if a vaccine induces a desired immune response, or predict which strains of flu will affect people in the coming flu season.

9/12/2016
URMC Neurologist Receives International Neurovirology Award

URMC Neurologist Receives International Neurovirology Award

Harris “Handy” Gelbard, M.D., Ph.D., will receive the Hilary Koprowski Prize in Neurovirology at the International Symposium on Molecular Medicine and Infectious Disease at Drexel University on September 14. The award  recognizes Gelbard's efforts to treat brain disorders associated with HIV. 

9/7/2016
Paciorkowski  Recognized for Research in Pediatric Neurologic Disorders

Paciorkowski Recognized for Research in Pediatric Neurologic Disorders

Neurologist Alexander R. Paciorkowski, M.D.  is being honored by the American Neurological Association (ANA) for his research in developmental disorders.  The award will be presented at the ANA’s annual meeting in October 2016.

8/23/2016
Pathologist Raises Questions About Polymer Coatings on Medical Devices

Pathologist Raises Questions About Polymer Coatings on Medical Devices

A University of Rochester Medical center pathologist warns that hydrophilic polymer coatings on catheters, guide wires, and other vascular medical devices can peel or flake off during clinical use and cause serious complications in some patients, including death. Her work has been cited by the U.S. Food and Drug Administration and was recently published in Human Pathology.

8/17/2016
Researchers Look to Improve Late-Stage Liver Cancer Therapy

Researchers Look to Improve Late-Stage Liver Cancer Therapy

Scientists discovered a potential therapy for late-stage liver cancer based on earlier work showing that the androgen receptor (AR), the protein that makes testosterone functional, plays a major role in regulating this type of malignancy. 

7/26/2016